Sign in
4

Changes in Ownership

Xenon Pharmaceuticals Inc. Filed Acc 0001209191-19-049550

Director acquired 31,892 shares (option exercise)

  • Director gave up 9,649 shares (to pay taxes)

From the SEC's structured data for this filing

Trades in this filing

HOLLER FRANK A · Director

Table I: Non-derivative

6 lines
Date Transaction Shares Price Value Owned after D/I
2019-09-12 Exercise or conversion : show line 1 in the form +3,086 $3.70 $11,418 122,041 D
2019-09-12 Shares withheld for taxes : show line 2 in the form −934 $9.38 $8,761 121,107 D
2019-09-12 Exercise or conversion : show line 3 in the form +3,086 $3.07 $9,474 124,193 D
2019-09-12 Shares withheld for taxes : show line 4 in the form −934 $9.38 $8,761 123,259 D
2019-09-12 Exercise or conversion : show line 5 in the form +25,720 $3.00 $77,160 148,979 D
2019-09-12 Shares withheld for taxes : show line 6 in the form −7,781 $9.38 $72,986 141,198 D

Table II: Derivative

3 lines
Date Transaction Shares Owned after D/I
2019-09-12 Exercise or conversion : show line 7 in the form Stock Option (Right to Buy) −3,086 0 D
2019-09-12 Exercise or conversion : show line 8 in the form Stock Option (Right to Buy) −3,086 0 D
2019-09-12 Exercise or conversion : show line 9 in the form Stock Option (Right to Buy) −25,720 0 D
Loading xslF345X03/doc4.xml…